Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arthur Tzianabos Insider Profile
4 Followers
Arthur Tzianabos, President and CSO at Tempest Therapeutics, holds 128.78K shares in Q32 Bio (Ticker: QTTB), holds 31.74K shares in Stoke Therapeutics (Ticker: STOK), holds 0.00 shares in AKOUOS (Ticker: AKUS).
Arthur Tzianabos Tempest Therapeutics (TPST)President and CSO
Tempest Therapeutics (TPST)
President and CSO
Ranked #86,301 out of 97,944 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-66.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Arthur Tzianabos holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 08, 2015 - Apr 08, 2016
Return:-66.40%
The most profitable trade made by Arthur Tzianabos
Arthur Tzianabos's Trading History
Tempest Therapeutics
Dec 07, 2015
President and CSO
Uninformative Buy
―
$55.70K
Q32 Bio
Feb 15, 2024
Director
Uninformative Buy
12.39K
$2.23M
Stoke Therapeutics
Feb 15, 2024
Director
Uninformative Buy
69.51K
$402.13K
AKOUOS
Dec 02, 2022
―
Uninformative Sell
―
$0.00
DNIB Unwind, Inc.
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Arthur Tzianabos's performance on stock
You May Also Like
Arthur Tzianabos insider profile FAQ
What is the percentage of profitable transactions made by Arthur Tzianabos?
The percentage of profitable transactions made by Arthur Tzianabos is 0%.
What is the average return per transaction made by Arthur Tzianabos?
The average return per transaction made by Arthur Tzianabos is -66.80%.
What stocks does Arthur Tzianabos hold?
Arthur Tzianabos holds: TPST, QTTB, STOK, AKUS, BINDQ stocks.
What was Arthur Tzianabos’s latest transaction?
Arthur Tzianabos latest transaction was an Uninformative Buy of $12.39K.
What was Arthur Tzianabos's most profitable transaction?
Arthur Tzianabos’s most profitable transaction was an Informative Buy of TPST stock on April 8, 2015. The return on the trade was -66.40%.
What is Arthur Tzianabos's role in Tempest Therapeutics?
Arthur Tzianabos's role in Tempest Therapeutics is President and CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.